Skip to main content

Table 1 Number of human SARS-CoV-2 strains in GISAID and the sample sizes included in this study for different periods

From: Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example

Period

Number of strains

in GISAID

in this study

Jan 1–31

6

6

Feb 1–29

16

16

Mar 1–10

72

30

Mar 11–20

94

30

Mar 21–31

158

30

Apr 1–10

100

30

Apr 11–20

21

21

Apr 21–30

50

30

May 1–10

7

7

Total

524

199